Terumo Europe NV - TPS

About Terumo Europe NV - TPS

Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety

Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services as well as a portfolio of injection, infusion, and primary packaging solutions.

Terumo Pharmaceutical Solutions has decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to the latest stages of product commercialization to optimize critical aspects of parenteral drug delivery.

  • BE
  • 2015
    On CPHI since
  • 3
  • 500 - 999
Company types
Primary activities
Medical Devices
Contact info
Meet us at

CPHI Korea 2022

COEX, Seoul, Korea
28 - 30 September 2022

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Pharmapack Europe 2023

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
1 & 2 Feb 2023

Products from Terumo Europe NV - TPS (11)

  • SurGuard®3 Safety Hypodermic Needles

    Product SurGuard®3 Safety Hypodermic Needles

    Equipped with Terumo’s patented three-way activation shield design, precision manufactured cannula and triple-bevel lancet, SurGuard®3 Safety Hypodermic Needles are carefully crafted to suit clinicians’ needs and assure patient comfort.
  • SurGuard®3 Safety Hypodermic Needles

    Product SurGuard®3 Safety Hypodermic Needles

    Designed for convenient one-handed activation, SurGuard®2 Safety Hypodermic Needles offer a simple needlestick protection solution combined with advanced cannula and tip technologies.
  • PLAJEX™ Ready-to-Fill Polymer Syringe with Tapered Needle

    Product PLAJEX™ Ready-to-Fill Polymer Syringe with Tapered Needle

    PLAJEX™ Ready-to-Fill Polymer Syringes with Tapered Needles offer the better injectability without compromising patient comfort for pharmaceutical manufacturers who need to overcome injectability problems associated with highly viscous concentrated formulations.

    (Assessment of the Injection Performance...
  • K-Pack® Surshield™ Needles with passive sharps protection

    Product K-Pack® Surshield™ Needles with passive sharps protection

    K-Pack® Surshield™ Needles for hypodermic injections with passive sharps protection offer a hypodermic needle with integrated needlestick prevention supporting both therapeutic success and  and reduction of the transmission risk induced by needle stick injuries at the same time.
  • K-Pack® II Needles

    Product K-Pack® II Needles

    Ready for your most challenging pharmaceutical applications K-Pack® II Needles for hypodermic injections are carefully crafted for smoother, less painful injections of today’s parenteral products.
  • PLAJEX™ Ready-to-Fill Polymer Syringe with Luer Lock

    Product PLAJEX™ Ready-to-Fill Polymer Syringe with Luer Lock

    PLAJEX™ Ready-to-Fill Polymer Syringes with Luer Lock offer the low drug-container interaction1 and secure connectivity for pharmaceutical manufacturers who need to deliver today’s most challenging parenteral drug products.
  • Nanopass® 34G Pen Needle

    Product Nanopass® 34G Pen Needle

    Nanopass® 34G Pen Needles feature the world's thinnest double-tapered needle and a unique asymmetric bevel precisely engineered for smoother penetrations and less painful injections.

    (Basic study of Nanopass II (34G  4 mm) for pen-type injector. Asakura T., Seino H., 2013, Jpn J Med Phar...
  • Surflo™ Winged Infusion Set with/without Needle Protection

    Product Surflo™ Winged Infusion Set with/without Needle Protection

    Surflo™ Winged Infusion Sets offer precision, stability and the patient comfort needed to deliver today’s most challenging and advanced therapeutics safely and confidently.

    SurfloTM Winged Infusion Sets with Needle Protection offer the needlestick prevention needed to deliver thera...
  • Nanopass® 32.5G Pen Needle

    Product Nanopass® 32.5G Pen Needle

    Available in three lengths, Nanopass® 32.5G Pen Needles unique asymmetric bevel design is engineered to reduce the pain of frequent, regular injections.

    (Patented technology)
  • PLAJEX™ Ready-to-Fill Polymer Syringe with Staked Needle

    Product PLAJEX™ Ready-to-Fill Polymer Syringe with Staked Needle

    PLAJEX™ Ready-to-Fill Polymer Syringes with Staked Needles provide lower interactions with proteins for pharmaceutical manufacturers who need to deliver today’s most challenging biopharmaceuticals.

    (Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syring...
  • Neolus® Needles

    Product Neolus® Needles

    Neolus® Needles for hypodermic injection offer drug product manufacturers a high performance single-use needle solution ready for today's parenteral formulations.

Terumo Europe NV - TPS Resources (17)

  • News Terumo Enters 100th Anniversary Year

    Terumo Corporation (TSE: 4543) is celebrating its 100th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021. The company has established 'Stride Ahead' as a slogan, to celebrate and connect all Terumo associates around the world. The phrase encompasses the company's belief that big steps forward will lead to a better future for healthcare.
  • Brochure Technology for today and tomorrow. Think Terumo.

    Our PLAJEX primary packaging solutions offer the functionality and compatibility needed to deliver today’s most challenging biologics and parenteral drug products.
  • News Terumo’s PLAJEX Provides a Solution for a New Osteoporosis Treatment Developed and Manufactured on Contract

    Terumo Corporation (TSE: 4543) today announced that a new osteoporosis medication, Teribone
    Asahi Kasei Pharma has been providing lyophilized vial formulation Teribone

  • Brochure Ready-to-fill Polymer syringes and had-case needles

    From the pioneer to the pacesetter for hard-case needles used in hypodermic drug application. Our K-Pack II needles have been designed for co-packing needs and have been crafted to deliver a better patient experience.
  • News Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

    - Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO -
    As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...

  • Brochure Surflo Winged Infusion Sets (with Filter) and Needle Protection, designed for comfort

    Our Surflo®️ portfolio incorporates the best of Terumo’s needle technology: Triple bevel for smooth skin penetration Interlocking, slightly angled wings for stability and grip Flexible tubing for a consistent flow Surshield®️ safety shield to reduce the risk of NSIs Microbore tubing available to reduce the dead space volume Optional, integrated 20µm filter
  • News Terumo’s PLAJEX™ Enters the US Market by Receiving GMP Certification from FDA to Manufacture Biosimilar Hulio

    Terumo Corporation (TSE: 4543) announced that its affiliate company Terumo Yamaguchi D&D Corporation has received Good Manufacturing Practice (GMP) certification from the US Food and Drug Administration (FDA), in regards to a bio...

  • Brochure We listen. We question. We deliver.

    Comprehensive parenteral delivery product portfolio: Pioneering hypodermic needle innovation designed for patient comfort. More confident, comfortable infusions. Ready to fill polymer syringes, ready for breakthrough formulations and demanding fill & finish processing environments.
  • News Terumo Pharmaceutical Solutions wins 2019 Asia-Pacific Industry Award

    Tokyo-based Terumo Pharmaceutical Solutions has been awarded the Asia-Pacific Bioprocessing Excellence Award 2019 at the 6th Biologics Manufacturing Asia & 3rd Bio logistics World Asia 2019 conferences in Singapore.
  • Brochure Extra-Thin Wall & Ultra-Thin Wall Technology for enhanced control and improved patient experience

    Terumo’s needle technology helps to use a higher gauge needle without having to compromise on performance. The advantages of the extra-& ultra-thin-wall features are: - Reduced delivery time due to higher flow rates when compared to regular wall type cannulas - Reduced extrusion forces as a result of lower flow resistance – for regular and for high viscosities All aiming to improve patient experience!
  • Video Self-infusion takes great courage; most people with hemophilia do it three times a week for the rest of their lives

    Among inherited blood disorders, hemophilia is often diagnosed early in childhood. Its debilitating symptoms afflict approximately 400,000 worldwide* and takes tremendous effort to treat effectively: Treatment includes frequent infusions Patients as young as eight must learn to treat themselves Requires scrupulous patient dose compliance For young patients it takes real courage to stick themselves with a needle, let alone the responsibility of doing it as many as three times a week. It’s a badge of courage they wear on the inside for the rest of their lives. Terumo Pharmaceutical Solutions felt they should have one to wear on the outside – something to let the world know how brave they really are.
  • Video Terumo Pharmaceutical Solutions. Our story.

    At Terumo Pharmaceutical Solutions, developing effective drug delivery devices is a true craft. It requires experience in medical technology for pharmaceuticals. The care and precision we put in the development of our products comes from our Japanese background.
  • Video Pathway To Overcome Primary Packaging & Drug Product Manufacturing (F&F) Challenges: Case Study, Ophthalmic Drugs

    This webinar will address: The global ophthalmic drug market is forecasted to reach $47.6 billion by 2030 with a growth driven by the rapidly ageing global population. Silicon oil-free technology contributes to achieve low subvisible particles and enable consistent and predictable glide forces for a better drug product system. The collaboration on fill & finish processes and primary containers contribute to improve filling accuracy, minimize headspace and maximize throughput while ensuring flexibility and time to market. Established collaboration such as Terumo and Swissfillon offers a best-in-class solution for ophthalmic projects This webinar originally aired as part of Pharmapack Europe 2021
  • Video Surflo™ Winged Infusion Sets with or without needle protection

    Surflo™ Winged Infusion Sets with Needle Protection offer precision, stability, and the needlestick prevention needed to deliver today’s most advanced therapeutics safely and confidently. 
    More Confident, Comfortable InfusionsIntegrating the best of Terumo Pharmaceutical Solutions’ needle technology with interlocking color-coded wings, Surflo® Winged Infusion Sets with Needle Protection (Surshield®) offer a simple needlestick prevention device with Terumo’s industry-leading T-SharpTM lancet design that reduces penetration pain¹.Surflo® Winged Infusion Sets Needle Protection (Surshield®) offer the quality and supply reliability drug developers need to meet parenteral delivery challenges and product commercialization goals.
  • Video PLAJEX TM Ready-to-Fill Polymer Syringe with Tapered Needle

    The PLAJEX TM Tapered Needle is designed for better injectability without compromising patient comfort. Resistance to flow can be reduced by using a conically-shaped needle with small diameter at the tip and a larger diameter at the bottom.
  • Webinar Solution for Challenging Low Dose PFS Projects - Case Study: Ophthalmic Drugs

    In this webinar, originally broadcast as part of Pharmapack Europe 2022, speaker from Terumo will be addressing the industry challenges and how Terumo Pharmaceutical Solutions can provide you a solution with their silicone oil-free prefillable syringes. There are increasing number of patients who requires ophthalmic drugs administered by intravitreal injection, triggered by the rapidly ageing global population. On the other hand, there are still several unmet challenges to design a prefilled syringe for safe administration of ophthalmic drugs. For example, it is known that silicone oil would be deposited in the eye’s vitreous body after repeated injections and cannot be evacuated. It is also a challenge to precisely deliver a dose as low as 50 microlitre, which is a typical administration volume for currently available ophthalmic drugs.